Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Oncotarget|January 18, 2015
Androgen receptors beyond prostate cancer: an old marker as a new targetJavier Munoz, Jennifer J Wheler, Razelle KurzrockTargeted Oncology|February 13, 2013
Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutationFilip Janku, Jennifer J Wheler, David S Hong, et al.Journal of Cachexia, Sarcopenia and Muscle|July 30, 2013
A pilot study of temsirolimus and body compositionHeloisa Veasey-Rodrigues, Henrique A Parsons, Filip Janku, et al.JCO Precision Oncology|September 11, 2020
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center StudyAnita Chawla, Filip Janku, Jennifer J Wheler, et al.BMC Cancer|May 30, 2015
Multiple gene aberrations and breast cancer: lessons from super-respondersJennifer J Wheler, Johnique T Atkins, Filip Janku, et al.Oncoscience|August 6, 2015
Challenges and perspective of drug repurposing strategies in early phase clinical trialsShumei Kato, Stacy L Moulder, Naoto T Ueno, et al.Oncotarget|March 12, 2015
Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancerIgor F Tsigelny, Jennifer J Wheler, Jerry P Greenberg, et al.Investigational New Drugs|April 24, 2013
Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumorsAung Naing, Siqing Fu, Ralph G Zinner, et al.International Journal of Cancer|September 8, 2016
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTERIshwaria M Subbiah, Jennifer J Wheler, Kenneth R Hess, et al.Cancer Chemotherapy and Pharmacology|January 31, 2016
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancerRabih Said, Yang Ye, David S Hong, et al.Pageof 8